-+ 0.00%
-+ 0.00%
-+ 0.00%

Regeneron Announces Promising Phase 2 Trial Results for Obesity Treatment Combining Semaglutide and Trevogrumab

Reuters·09/17/2025 13:30:39

Please log in to view news